Hong Kong · Delayed Price · Currency is HKD Shanghai Henlius Biotech Statistics
Total Valuation
HKG:2696 has a market cap or net worth of HKD 32.37 billion. The enterprise value is 35.43 billion.
| Market Cap | 32.37B |
| Enterprise Value | 35.43B |
Important Dates
The next estimated earnings date is Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2696 has 543.49 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 346.07M |
| Shares Outstanding | 543.49M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 19.16% |
| Float | 137.56M |
Valuation Ratios
The trailing PE ratio is 35.44 and the forward PE ratio is 23.03.
| PE Ratio | 35.44 |
| Forward PE | 23.03 |
| PS Ratio | 4.36 |
| PB Ratio | 7.34 |
| P/TBV Ratio | 67.05 |
| P/FCF Ratio | 29.25 |
| P/OCF Ratio | 22.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.71, with an EV/FCF ratio of 32.02.
| EV / Earnings | 38.50 |
| EV / Sales | 4.78 |
| EV / EBITDA | 25.71 |
| EV / EBIT | 38.96 |
| EV / FCF | 32.02 |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.91.
| Current Ratio | 0.71 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 2.91 |
| Debt / FCF | 3.62 |
| Interest Coverage | 7.97 |
Financial Efficiency
Return on equity (ROE) is 23.72% and return on invested capital (ROIC) is 12.17%.
| Return on Equity (ROE) | 23.72% |
| Return on Assets (ROA) | 4.45% |
| Return on Invested Capital (ROIC) | 12.17% |
| Return on Capital Employed (ROCE) | 11.01% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | 1.97M |
| Profits Per Employee | 244,641 |
| Employee Count | 3,762 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.51 |
Taxes
| Income Tax | -17.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.04% in the last 52 weeks. The beta is 0.51, so HKG:2696's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +34.04% |
| 50-Day Moving Average | 71.10 |
| 200-Day Moving Average | 69.10 |
| Relative Strength Index (RSI) | 48.44 |
| Average Volume (20 Days) | 882,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2696 had revenue of HKD 7.42 billion and earned 920.34 million in profits. Earnings per share was 1.68.
| Revenue | 7.42B |
| Gross Profit | 5.55B |
| Operating Income | 909.30M |
| Pretax Income | 903.29M |
| Net Income | 920.34M |
| EBITDA | 1.29B |
| EBIT | 909.30M |
| Earnings Per Share (EPS) | 1.68 |
Balance Sheet
The company has 938.37 million in cash and 4.00 billion in debt, with a net cash position of -3.06 billion or -5.64 per share.
| Cash & Cash Equivalents | 938.37M |
| Total Debt | 4.00B |
| Net Cash | -3.06B |
| Net Cash Per Share | -5.64 |
| Equity (Book Value) | 4.41B |
| Book Value Per Share | 8.11 |
| Working Capital | -1.62B |
Cash Flow
In the last 12 months, operating cash flow was 1.45 billion and capital expenditures -346.50 million, giving a free cash flow of 1.11 billion.
| Operating Cash Flow | 1.45B |
| Capital Expenditures | -346.50M |
| Depreciation & Amortization | 401.24M |
| Net Borrowing | 10.58M |
| Free Cash Flow | 1.11B |
| FCF Per Share | 2.04 |
Margins
Gross margin is 74.77%, with operating and profit margins of 12.26% and 12.41%.
| Gross Margin | 74.77% |
| Operating Margin | 12.26% |
| Pretax Margin | 12.18% |
| Profit Margin | 12.41% |
| EBITDA Margin | 17.45% |
| EBIT Margin | 12.26% |
| FCF Margin | 14.91% |
Dividends & Yields
HKG:2696 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.45% |
| Earnings Yield | 2.84% |
| FCF Yield | 3.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:2696 is 102.86, which is 63.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 102.86 |
| Price Target Difference | 63.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 9.90% |
| EPS Growth Forecast (3Y) | 10.12% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2696 has an Altman Z-Score of 2.19 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.19 |
| Piotroski F-Score | 6 |